AKT1 and hepatocellular carcinoma: Liu et al. found that FAM83G could act as an oncogenic factor to predict overall survival in patients with hepatocellular carcinoma and facilitate the progression of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway (Liu et al., 2021).